Frequently Asked Questions About Accessing FORZINITY™ (elamipretide)

The United States’ Food and Drug Administration (FDA) approved FORZINITY for individuals living in the United States who are genetically confirmed to have Barth syndrome and weigh 30 kg (66 lbs) or more.

Below, please find answers to some of the most frequently asked questions. This is a living document, and we will update it as we learn more. 

If you have additional questions you would like answered in our communications, please submit your question here.

Please note we are not able to respond individually to submissions to this form due to the high number of questions we are receiving, but we're committed to sharing more information as it becomes available.